JD Capital To Take Control Of Chinese Traditional Medicine Maker For $42M

Investment Research Team
November 28, 2014 — 22:51 CST

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!

Already have an account or paid subscription? Log in

Related Topics: Beijing chinese drug maker healthcare Hebei JD Capital Company JD finance medicine news media pharmaceutical Private Equity

Related News:

China To Expand Investment Scope for Its National Social Security Fund

December 8, 2023 — 00:03

US’s Top 10 Public Companies Worth Over Five Times Than China’s Top 10

December 21, 2021 — 23:37

China Tech Digest: Tencent Unveils Three Self-developed Chips; Huawei’s Autonomous Driving Unit Founder Joins Zeekr

November 4, 2021 — 09:39

China’s Beidou Satellite System Finds Another Application: Sending Early Warnings For Landslide

March 3, 2021 — 03:17

China, With 1.4 Billion People, Faces Looming Demographic Crisis

February 18, 2021 — 04:48

Labor Dispute Soars At Chinese Tech Giants Driven By Insufficient Innovation, Competition

February 16, 2021 — 03:20

China Tech Digest: Luckin Coffee Files For Bankruptcy In New York

February 6, 2021 — 07:36

SMIC CEO Zhao Haijun Says Company Can Ensure Continuous Production For 3 Months

February 6, 2021 — 05:46

Pandemic Pushes China’s Sports Tech To New Heights And New Models

February 6, 2021 — 05:23

Franchising and Licensing Asia (FLAsia) 2024